Showing results (71-80 of 219) with videos related to
Sort By:
Pageof 22
Molecular Cancer Therapeutics|July 30, 2009
Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell linesZhenfeng Duan, Edwin Choy, David Harmon, et al.Molecular Cancer Therapeutics|May 22, 2016
Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to PaclitaxelXianzhe Liu, Yan Gao, Jacson Shen, et al.Scientific Reports|May 10, 2016
Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and ratsYan Gao, Jacson K Shen, Edwin Choy, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 2, 2017
CDK4 expression in chordoma: A potential therapeutic targetTang Liu, Jacson K Shen, Edwin Choy, et al.Spine|June 3, 2016
Frequency and Risk Factors for Additional Lesions in the Axial Spine in Subjects With Chordoma: Indications for ScreeningRonnie Sebro, Thomas F DeLaney, Francis Hornicek, et al.Molecular Cancer Therapeutics|August 9, 2008
Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancerZhenfeng Duan, Edward J Weinstein, Diana Ji, et al.Cancer Chemotherapy and Pharmacology|October 2, 2008
Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell linesZhenfeng Duan, Edwin Choy, Jose Maria Jimeno, et al.Anti-Cancer Drugs|March 15, 2011
Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivoXianzhe Liu, Edwin Choy, David Harmon, et al.Scientific Reports|February 18, 2015
MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancerXiaoqian Yang, Arun K Iyer, Amit Singh, et al.The American Journal of Surgical Pathology|September 29, 2015
Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of BoneJohn Wojcik, Andrew E Rosenberg, Miriam A Bredella, et al.Pageof 22